Aminoglycosides do not improve the efficacy of cephalosporins for treatment of acute pyelonephritis in women

Scandinavian Journal of Infectious Diseases

Volumn 29, Issue 2, 1997, Pages 175-179

  Sandberg, Torsten ^a   Alestig, Kjell ^a   Eilard, Tönnes ^b   Ek, Elisabeth ^a   Hebelka, Miroslav ^c   Johansson, Eva ^b   Olinder Nielsen, Ann Margreth ^d  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b CENTRAL HOSPITAL   (Sweden)

^c Central Hospitals   (Sweden)

^d Central Hospital   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM ANTIBIOTIC; C REACTIVE PROTEIN; CEFADROXIL; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; TOBRAMYCIN;

ACUTE PYELONEPHRITIS; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; RECURRENCE RISK; TIME; VULVOVAGINITIS;

EID: 0030966480     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549709035880     Document Type: Article

References (16)

1. Sandberg T, Englund G, Lincoln K, Nilsson L-G. Randomised double-blind study of norfloxacin and cefadroxil in the treatment of acute pyelonephritis. Eur J Clin Microbiol Infect Dis 9: 317-323, 1990.
2. Stamm WE, McKevitt M, Counts GW. Acute renal infection in women: treatment with trimethoprim-sulfamethoxazole or ampicillin for two or six weeks. Ann Intern Med 160: 341-345, 1987.
3. Gentry LO, Wood BA, Martin MD, Smythe J. Cefamandole alone and combined with gentamicin or tobramycin in the treatment of acute pyelonephritis. Scand J Infect Dis 12 Suppl 25: 96-100, 1980.
4. Eriksson S, Zbornik J, Dahnsjö H, Erlanson P, Kahlmeter O, Fritz H, Bauer C-A. The combination of pivampicillin and pivmecillinam versus pivampicillin alone in the treatment of acute pyelonephritis. Scand J Infect Dis 18: 431-438, 1986.
5. Jernelius H, Zbornik J, Bauer C-A. One or three weeks' treatment of acute pyelonephritis? Acta Med Scand 223: 469-477, 1988.
6. Cronberg S, Banke S, Bruno A-M, Carlsson M, Elmrud H, Elowsson S, Josefsson K, Lindholm A-C, Montelius H, Neringer R, Ode B, Stenlund G, Svantesson B, Thorén A, Walder M, Wallmark E. Ampicillin plus mecillinam vs cefotaxime/cefadroxil treatment of patients with severe pneumonia or pyelonephritis: a double-blind multicentre study evaluated by intention-to-treat analysis. Scand J Infect Dis 27: 463-468, 1995.
7. Bergeron MG. Therapeutic potential of high renal levels of aminoglycosides in pyelonephritis. J Antimicrob Chemother 15: 4-8, 1985.
8. Bergeron MG, Marois Y. Benefit from high intrarenal levels of gentamicin in the treatment of E. coli pyelonephritis. Kidney Int 30: 481-487, 1986.
9. Lidin-Janson G, Falsen E, Jodal U, Kaijser B, Lincoln K. Characteristics of antibiotic-resistant Escherichia coli in the rectum of healthy school-children. J Med Microbiol 10: 299-308, 1977.
10. Bradley JW. Distribution-free statistical tests. London: Prentice-Hall, 68-86, 1968.
11. Mantel N. Chi-square tests with one degree of freedom. Extensions of the Mantel-Haenszel procedure. J Am Statistical Assoc 58: 690-700, 1963.
12. Stamey TA, Timothy M, Millar M, Mihara G. Recurrent urinary infections in adult women. The role of introital enter-obacteria. Calif Med 115: 1-19, 1971.
13. Edlund C, Nord CE. A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora. Infection 16: 8-12, 1988.
14. Tartaglione TA, Johnson CR, Brust P, Opheim K, Hooton TM, Stamm WE. Pharmacodynamic evaluation of ofloxacin and trimethoprim-sulfamethoxazole in vaginal fluid of women treated for acute cystitis. Antimicrob Agents Chemother 32: 1640-1643, 1988.
15. Winberg J, Herthelius-Elman M, Möllby R, Nord CE. Pathogenesis of urinary tract infection-experimental studies of vaginal resistance to colonization. Pediatr Nephrol 7: 509-514, 1993.
16. Larsson, P, Lincoln K, Lind L, Sandberg T. Variable in vitro activity of cefaclor, cephalothin and cefadroxil against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. Scand J Infect Dis 20: 421-424, 1988.